IpamorelinInterpret the evidence
Why weight and vomiting were separate outcomes in a ferret experiment
2 numbered sourcesSource years 2024
Peptides are short chains of amino acids joined by peptide bonds. Some act on receptors involved in feeding and digestive function. Ipamorelin is a synthetic five-residue peptide that activates the ghrelin receptor, also called the growth hormone secretagogue receptor. A study in ferrets asked whether this signal affected weight change and vomiting after exposure to a chemotherapy drug. [1, 2]
No recent primary study repeating the exact animal comparison was identified. In the older 2024 experiment, researchers studied ferrets exposed to cisplatin, a drug that can cause vomiting and reduced food intake. They compared ipamorelin, a different ghrelin-receptor agonist called anamorelin, and a control condition. They measured food and water consumption, weight change and episodes of vomiting. They also compared the compounds in an isolated section of ferret intestine. [1]
In the comparison that included ipamorelin, the investigators saw less weight loss late in the observation window but did not detect a change in vomiting. In a separate experiment they observed a change in early vomiting after administering anamorelin in a way that tested a central effect. That observation involved anamorelin, a distinct compound, and cannot be assigned to ipamorelin. [1]
The older study shows why the effects of two receptor agonists should be attributed to their specific compounds and endpoints. A difference in weight over several days can occur without a change in vomiting, and it does not establish a change in long-term body composition. These were animal findings with a particular chemotherapy exposure. They do not show that ipamorelin helps people receiving chemotherapy. [1, 2]
Sources
Original works cited in this article. Links open the external record in a new tab.
- 1.Lu Z et al. The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism. Physiology & Behavior (publication 2024-07-21). (opens in a new tab)
pubmed.ncbi.nlm.nih.gov↩ Back to text
